Thijs J. Giezen

Safety-Related Regulatory Actions for Biologicals Approved in the United States and the European Union

Thijs J. Giezen, Aukje K. Mantel‐Teeuwisse, Sabine M. J. M. Straus et al. · JAMA · 2008 · 266 citations

Interchangeability of Biosimilars: A European Perspective

Pekka Kurki, Leon van Aerts, Elena Wolff‐Holz et al. · BioDrugs · 2017 · 171 citations

Xenotransplantation, Engineering, Biobank +7

Evaluation of Post-Authorization Safety Studies in the First Cohort of EU Risk Management Plans at Time of Regulatory Approval

Thijs J. Giezen, Aukje K. Mantel‐Teeuwisse, Sabine M. J. M. Straus et al. · Drug Safety · 2009 · 58 citations

Regulatory Approval, Engineering, Health Policy +15

Mapping the Safety Profile of Biologicals

Thijs J. Giezen, Aukje K. Mantel‐Teeuwisse, Ronald H.B. Meyboom et al. · Drug Safety · 2010 · 52 citations

Safety Science, Toxicology, Microbiology +4

Safety-Related Regulatory Actions for Orphan Drugs in the US and EU

Harald E. Heemstra, Thijs J. Giezen, Aukje K. Mantel‐Teeuwisse et al. · Drug Safety · 2010 · 39 citations

Drug Safety, Substance Abuse, Regulatory Approval +11